Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Identification of enhanced IFN-γ signaling in polyarticular juvenile idiopathic arthritis with mass cytometry
Allison A. Throm, Halima Moncrieffe, Amir B. Orandi, Jeanette T. Pingel, Theresa L. Geurs, Hannah L. Miller, Allyssa L. Daugherty, Olga N. Malkova, Daniel J. Lovell, Susan D. Thompson, Alexei A. Grom, Megan A. Cooper, Stephen T. Oh, Anthony R. French
Allison A. Throm, Halima Moncrieffe, Amir B. Orandi, Jeanette T. Pingel, Theresa L. Geurs, Hannah L. Miller, Allyssa L. Daugherty, Olga N. Malkova, Daniel J. Lovell, Susan D. Thompson, Alexei A. Grom, Megan A. Cooper, Stephen T. Oh, Anthony R. French
View: Text | PDF
Research Article Immunology Inflammation

Identification of enhanced IFN-γ signaling in polyarticular juvenile idiopathic arthritis with mass cytometry

  • Text
  • PDF
Abstract

Polyarticular juvenile idiopathic arthritis (JIA) is among the most challenging of the JIA subtypes to treat. Even with current biologic therapies, the disease remains difficult to control in a substantial subset of patients, highlighting the need for new therapies. The aim of this study was to use the high dimensionality afforded by mass cytometry with phospho-specific antibodies to delineate signaling abnormalities in immune cells from treatment-naive polyarticular JIA patients. Peripheral blood mononuclear cells were isolated from 17 treatment-naive polyarticular JIA patients, 10 of the patients after achieving clinical remission, and 19 healthy controls. Samples were stimulated for 15 minutes with IL-6 or IFN-γ and analyzed by mass cytometry. Following IFN-γ stimulation, increased STAT1 and/or STAT3 phosphorylation was observed in subsets of CD4 T cells and classical monocytes from treatment-naive patients. The enhanced IFN-γ signaling was associated with increased expression of JAK1 and SOCS1 in CD4 T cells. Furthermore, substantial heterogeneity in surface marker expression was observed among the subsets of CD4 T cells and classical monocytes with increased IFN-γ responsiveness. The identification of enhanced IFN-γ signaling in CD4 T cells and classical monocytes from treatment-naive polyarticular JIA patients provides mechanistic support for investigations into therapies that attenuate IFN-γ signaling in this disease.

Authors

Allison A. Throm, Halima Moncrieffe, Amir B. Orandi, Jeanette T. Pingel, Theresa L. Geurs, Hannah L. Miller, Allyssa L. Daugherty, Olga N. Malkova, Daniel J. Lovell, Susan D. Thompson, Alexei A. Grom, Megan A. Cooper, Stephen T. Oh, Anthony R. French

×

Figure 3

Heterogeneity in the naive CD4 T cells with enhanced responsiveness to IFN-γ stimulation in polyarticular JIA patients.

Options: View larger image (or click on image) Download as PowerPoint
Heterogeneity in the naive CD4 T cells with enhanced responsiveness to I...
(A) Schematic of hierarchical clustering computed by Citrus, with clusters analyzed in B and C denoted by boxes. Nonstratifying clusters between patient and control samples are light blue for FDR < 0.05, p-STAT1 stratifying (different between patient and control samples in regard to the phosphorylation of a specific signaling molecule) clusters are purple, p-STAT3 stratifying clusters are orange, and clusters stratifying for both p-STAT1 and p-STAT3 are red. (B) CD11c, CD45RA, and CD38 arcsinh-transformed medians in 3 proximal nodes in the CD4 T cell branch of clustering tree (ANOVA with Dunnett’s post hoc, *P < 0.05). Data represent mean ± SEM. (C) CD27, CD45RA, and CD38 arcsinh-transformed medians in 3 distal nodes in the CD4 T cell branch of clustering tree (ANOVA with Dunnett’s post hoc, *P < 0.05). Data represent mean ± SEM. n = 15 IFN-γ–stimulated treatment-naive patients, patients 4 and 5 in Table 1 did not have enough cells for an IFN-γ–stimulated sample and were excluded here; n = 19 controls.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts